Improving our understanding of factors influencing patient outcomes in pleural disease
- Conditions
- Respiratory
- Registration Number
- ISRCTN17535598
- Lead Sponsor
- orth Bristol NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 1000
1. Confirmed presence (radiologically) of either:
1.1. Pleural effusion/pleural thickening OR
1.2. Spontaneous primary or secondary pneumothorax
2. Patient normally lives within the catchment area of the Bristol hospitals and is unlikely to relocate within 12 months
3. Aged 16 years old and over
4. Has access to telephone and/or internet
To be eligible to participate in the cohort, none of the following criteria should apply:
1. Previously enrolled in SPOTLight
2. Patient (or appropriate proxy) is not able to provide written informed consent
3. Patient is in the final stages of life or sufficiently frail to make study involvement inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Breathlessness and pain measured using the patient-reported outcome measures (PROMs) Visual Analogue Scale (VAS) at baseline, 4 months and 12 months<br>2. Health-related quality of life measured using the EuroQol 5D Health Questionnaire (EQ-5D-5L) at baseline, 4 months and 12 months
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures